SI-BONE Inc.

14.61
-0.35 (-2.34%)
At close: Mar 21, 2025, 3:59 PM
-2.34%
Bid 14.5
Market Cap 620.24M
Revenue (ttm) 170.64M
Net Income (ttm) -31.55M
EPS (ttm) -0.75
PE Ratio (ttm) -19.48
Forward PE -26.51
Analyst Buy
Ask 18.76
Volume 358,318
Avg. Volume (20D) 368,549
Open 14.87
Previous Close 14.96
Day's Range 14.58 - 14.94
52-Week Range 11.70 - 19.16
Beta 1.17

About SIBN

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section...

Sector Healthcare
IPO Date Oct 17, 2018
Employees 349
Stock Exchange NASDAQ
Ticker Symbol SIBN
Full Company Profile

Analyst Forecast

According to 7 analyst ratings, the average rating for SIBN stock is "Buy." The 12-month stock price forecast is $25, which is an increase of 71.12% from the latest price.

Stock Forecasts

Next Earnings Release

SI-BONE Inc. is scheduled to release its earnings on May 5, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+5.55%
SI-BONE shares are trading higher after the compan... Unlock content with Pro Subscription
2 months ago
+18.29%
SI-BONE shares are trading higher after the company reported preliminary Q4 revenue results.